In November 2021, Maria Leptin became president of the European Research Council. After a long career in biological research, Leptin admits that starting the process of closing her lab at the European Molecular Biology Organization (EMBO) before taking up her new role, was difficult. “You win some you lose some,” she tells Nature careers editor Jack Leeming of this new career step. “It's painful, but that's the decision I've made.”
Leptin shares some advice for early career researchers writing grants and how researchers can advocate for more funding of science from politicians. She also speaks about the different types of research that deserve to be funded. It doesn’t all need to be ground-breaking, she says, adding: “Just because it's incremental and is not another breakthrough, doesn't mean it's not important. It's extremely important.”
This episode is part of an ongoing Working Scientist podcast series about funding in science.
Hosted on Acast. See acast.com/privacy for more information.
